Dr. Martens (3U2) Stock Overview
Engages in the design, development, procurement, marketing, sale, and distribution of footwear. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
3U2 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Dr. Martens plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.90 |
| 52 Week High | UK£1.11 |
| 52 Week Low | UK£0.49 |
| Beta | 0.24 |
| 1 Month Change | 6.55% |
| 3 Month Change | -14.76% |
| 1 Year Change | 7.83% |
| 3 Year Change | -56.55% |
| 5 Year Change | n/a |
| Change since IPO | -84.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3U2 | DE Luxury | DE Market | |
|---|---|---|---|
| 7D | 7.8% | 0.7% | 0.3% |
| 1Y | 7.8% | -30.7% | 14.2% |
Return vs Industry: 3U2 exceeded the German Luxury industry which returned -32% over the past year.
Return vs Market: 3U2 underperformed the German Market which returned 13.5% over the past year.
Price Volatility
| 3U2 volatility | |
|---|---|
| 3U2 Average Weekly Movement | 8.0% |
| Luxury Industry Average Movement | 3.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in DE Market | 12.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 3U2's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 3U2's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 3,700 | Ije Nwokorie | www.drmartensplc.com |
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens plc Fundamentals Summary
| 3U2 fundamental statistics | |
|---|---|
| Market cap | €840.47m |
| Earnings (TTM) | €17.55m |
| Revenue (TTM) | €900.63m |
Is 3U2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3U2 income statement (TTM) | |
|---|---|
| Revenue | UK£785.00m |
| Cost of Revenue | UK£270.70m |
| Gross Profit | UK£514.30m |
| Other Expenses | UK£499.00m |
| Earnings | UK£15.30m |
Last Reported Earnings
Sep 28, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.016 |
| Gross Margin | 65.52% |
| Net Profit Margin | 1.95% |
| Debt/Equity Ratio | 75.7% |
How did 3U2 perform over the long term?
See historical performance and comparisonDividends
Does 3U2 pay a reliable dividends?
See 3U2 dividend history and benchmarks| Dr. Martens dividend dates | |
|---|---|
| Ex Dividend Date | Mar 05 2026 |
| Dividend Pay Date | Apr 09 2026 |
| Days until Ex dividend | 64 days |
| Days until Dividend pay date | 99 days |
Does 3U2 pay a reliable dividends?
See 3U2 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/29 16:57 |
| End of Day Share Price | 2025/12/29 00:00 |
| Earnings | 2025/09/28 |
| Annual Earnings | 2025/03/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Martens plc is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Taylor | Barclays |
| Anne Critchlow | Berenberg |
| David Roux | BofA Global Research |